Snowball logo
logo
2561

VISEN Pharmaceuticals

2561 β€’ HK
HK$15.00-HK$0.50Β  (3.23%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
-(2.029052)(1.51764)2.6094460.16072920.4
COGS
4.622247---0.1422216.63
Gross Profit
(4.622247)(2.029052)(1.51764)2.6094460.01853.777
Operating Expenses & Income
Operating Income
(367.7)(316.4)(126.2)(163.7)(233.6)(236.1)
Total Operating Expenses
363316.4126.2163.7233.6239.9
R&D Expenses
224.8158.552.4685.0691.0684.24
Selling General & Admin Expenses
-36.6614.8781.22115.188.69
Earnings from Continuing Operations
Interest Expense
(0.601547)(0.546555)(0.288252)(0.151286)(1.069581)-
Interest Income
-0.5465550.2882520.1512861.0981.059
Income Tax Expense
------
Net Income
Net Income
(397.3)(255.1)(226.9)(171.2)(246.9)(239.5)
Supplemental
EBIT
(367.7)(254.6)(226.6)(171.1)(239.8)(236.1)
EBITDA
(363)(248.1)(220.3)(166.9)(236.7)(233.1)
In millions of HKD, except % and values per 1 share